These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29487356)

  • 1. Enteropathogenic E. coli effectors EspF and Map independently disrupt tight junctions through distinct mechanisms involving transcriptional and post-transcriptional regulation.
    Singh AP; Sharma S; Pagarware K; Siraji RA; Ansari I; Mandal A; Walling P; Aijaz S
    Sci Rep; 2018 Feb; 8(1):3719. PubMed ID: 29487356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinated transient interaction of ZO-1 and afadin is required for pedestal maturation induced by EspF from enteropathogenic Escherichia coli.
    Ugalde-Silva P; Navarro-Garcia F
    Microbiologyopen; 2019 Dec; 8(12):e931. PubMed ID: 31568664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity.
    Tapia R; Kralicek SE; Hecht GA
    Cell Microbiol; 2017 Nov; 19(11):. PubMed ID: 28618099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Ugalde-Silva P; Gonzalez-Lugo O; Navarro-Garcia F
    Front Cell Infect Microbiol; 2016; 6():87. PubMed ID: 27606286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EspF Interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability.
    Peralta-Ramírez J; Hernandez JM; Manning-Cela R; Luna-Muñoz J; Garcia-Tovar C; Nougayréde JP; Oswald E; Navarro-Garcia F
    Infect Immun; 2008 Sep; 76(9):3854-68. PubMed ID: 18559425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis.
    Viswanathan VK; Weflen A; Koutsouris A; Roxas JL; Hecht G
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1165-70. PubMed ID: 18356531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tight junctions and enteropathogenic E. coli.
    Weflen AW; Alto NM; Hecht GA
    Ann N Y Acad Sci; 2009 May; 1165():169-74. PubMed ID: 19538303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo.
    Shifflett DE; Clayburgh DR; Koutsouris A; Turner JR; Hecht GA
    Lab Invest; 2005 Oct; 85(10):1308-24. PubMed ID: 16127426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteropathogenic
    Tapia R; Kralicek SE; Hecht GA
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Map, but not EspF, induces breast epithelial cell apoptosis through ERK/DRP-1 pathway.
    Li Y; Zhu Y; Chu B; Liu N; Chen S; Wang J
    Vet Microbiol; 2022 Mar; 266():109367. PubMed ID: 35183820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tricellular Tight Junction Protein Tricellulin Is Targeted by the Enteropathogenic Escherichia coli Effector EspG1, Leading to Epithelial Barrier Disruption.
    Morampudi V; Graef FA; Stahl M; Dalwadi U; Conlin VS; Huang T; Vallance BA; Yu HB; Jacobson K
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli.
    Thanabalasuriar A; Koutsouris A; Weflen A; Mimee M; Hecht G; Gruenheid S
    Cell Microbiol; 2010 Jan; 12(1):31-41. PubMed ID: 19712078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a MDCK cell line with constitutive expression of the Enteropathogenic E. coli effector protein Map as an in vitro model of pathogenesis.
    Singh AP; Aijaz S
    Bioengineered; 2015; 6(6):335-41. PubMed ID: 26430918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redistribution of tight junction proteins during EPEC infection in vivo.
    Zhang Q; Li Q; Wang C; Li N; Li J
    Inflammation; 2012 Feb; 35(1):23-32. PubMed ID: 21170673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function.
    Viswanathan VK; Koutsouris A; Lukic S; Pilkinton M; Simonovic I; Simonovic M; Hecht G
    Infect Immun; 2004 Jun; 72(6):3218-27. PubMed ID: 15155623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-terminal proline-rich repeats of Enteropathogenic E. coli effector EspF are sufficient for the depletion of tight junction membrane proteins and interactions with early and recycling endosomes.
    Ansari I; Mandal A; Kansal K; Walling P; Khan S; Aijaz S
    Gut Pathog; 2024 Jul; 16(1):36. PubMed ID: 38972985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteropathogenic Escherichia coli dynamically regulates EGFR signaling in intestinal epithelial cells.
    Roxas JL; Ryan K; Vedantam G; Viswanathan VK
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G374-80. PubMed ID: 24904077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction.
    Alvarez CS; Giménez R; Cañas MA; Vera R; Díaz-Garrido N; Badia J; Baldomà L
    BMC Microbiol; 2019 Jul; 19(1):166. PubMed ID: 31315566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein.
    Dean P; Kenny B
    Mol Microbiol; 2004 Nov; 54(3):665-75. PubMed ID: 15491358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity.
    Hodges K; Alto NM; Ramaswamy K; Dudeja PK; Hecht G
    Cell Microbiol; 2008 Aug; 10(8):1735-45. PubMed ID: 18433466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.